L-Chicoric Acid
(Synonyms: L-菊苣酸; (-)-Chicoric acid; trans-Caffeoyltartaric acid) 目录号 : GC60978A dicaffeoyl ester with diverse biological activities
Cas No.:70831-56-0
Sample solution is provided at 25 µL, 10mM.
Chicoric acid is a dicaffeoyl ester that has been found in C. intybus with diverse biological activities.1 Chicoric acid (50-200 μg/ml) dose-dependently reduces the viability of Caco-2 and HCT116 human colorectal cancer cells.2 It inhibits HIV integrase activities, including 3'-processing of a DNA oligonucleotide and integration with template DNA (IC50s = 1.1 and 0.8 μM, respectively).3 Chicoric acid (0.5-10 μM) noncompetitively inhibits integration of HIV DNA by HIV integrase and, at concentrations greater than or equal to 5 μM, inhibits HIV entry into H9 cells.4 Oral administration of chicoric acid (10 and 30 mg/kg) reduces hepatic lipid accumulation, lipid peroxidation, and fibrosis, inhibits production of pro-inflammatory cytokines and activation of NF-kB, and activates the AMPK signaling pathway in a mouse model of non-alcoholic steatohepatitis (NASH) induced by a methionine and choline-deficient diet.5 Chicoric acid (2 mg/kg) also reduces blood glucose levels by 54% in mice with streptozotocin-induced diabetes.6
1.Xiao, H., Xie, G., Wang, J., et al.Chicoric acid prevents obesity by attenuating hepatic steatosis, inflammation and oxidative stress in high-fat diet-fed miceFood Res. Int.54(1)345-353(2013) 2.Tsai, Y.-L., Chiu, C.-C., Chen, J.Y.-F., et al.Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosisJ. Ethnaopharmacol.143(3)914-919(2012) 3.Lin, Z., Neamati, N., Zhao, H., et al.Chicoric acid analogues as HIV-1 integrase inhibitorsJ. Med. Chem.42(8)1401-1414(1999) 4.Reinke, R.A., Lee, D.J., McDougall, B.R., et al.L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitroVirology326(2)203-219(2004) 5.Kim, M., Yoo, G., Randy, A., et al.Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiencyMol. Nutr. Food Res.61(5)(2017) 6.Casanova, L.M., da Silva, D., Sola-Penna, M., et al.Identification of chicoric acid as a hypoglycemic agent from Ocimum gratissimum leaf extract in a biomonitoring in vivo studyFiloterapia93132-141(2014)
Cas No. | 70831-56-0 | SDF | |
别名 | L-菊苣酸; (-)-Chicoric acid; trans-Caffeoyltartaric acid | ||
Canonical SMILES | O=C(O[C@@H](C(O)=O)[C@H](C(O)=O)OC(/C=C/C1=CC=C(O)C(O)=C1)=O)/C=C/C2=CC=C(O)C(O)=C2.[Rotation(-)] | ||
分子式 | C22H18O12 | 分子量 | 474.37 |
溶解度 | DMSO: 100 mg/mL (210.81 mM) | 储存条件 | -20°C, stored under nitrogen |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.1081 mL | 10.5403 mL | 21.0806 mL |
5 mM | 0.4216 mL | 2.1081 mL | 4.2161 mL |
10 mM | 0.2108 mL | 1.054 mL | 2.1081 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet